2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2021-11-11 c-LEcta expands product range to include additional enzyme NuCLEANase® c-LEcta, a global biotechnology company with technology leadership in enzyme engineering and bioprocess development, is launching a newly developed... read more 2021-10-14 OFB Projektentwicklung realises biotechnology campus in Leipzig and thus creates new headquarters for c-LEcta Leipzig, 14.10.2021 OFB is developing a biotechnology campus in Leipzig by the fourth quarter of 2024. The first section with around 10,425 m² of... read more 2021-09-22 Successful development of a screening method in Bacillus c-LEcta expands its ENESYZ® technology platform, using enzyme engineering to optimize more enzymes with better results. read more 2021-08-31 Drug Master File for the use of the enzyme DENARASE® in the pharmaceutical industry accepted by the US FDA Successful submission of a Master File to the U.S. Food and Drug Administration for the product DENARASE®, with assigned reference number MF 27708 read more 2021-06-15 c-LEcta exceeds EUR 10 million in revenue with significantly higher EBITDA c-LEcta managed to grow strongly once again in 2020. Despite a generally challenging economic environment, revenue in the past fiscal year rose by 14%... read more 2021-05-26 European dossiers submitted for approval of new enzymes in the food industry c-LEcta has submitted dossiers for two newly developed enzymes in the food sector. The evaluation by EFSA (European Food Safety Agency) and the EU... read more 2021-03-18 Plastic waste from c-LEcta laboratories gets second chance c-LEcta is donating their plastic waste from laboratory to the Kunststofferei, Leipzig - the local department of global Precious Plastic initiative. read more 2021-03-02 EXCiPACT certification for c-LEcta’s high production standards The certificate confirms compliance with particularly high quality standards in production and distribution. For customers from the pharmaceutical... read more